===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
current report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of earliest event reported: February 20, 2003
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
===============================================================================
Item 5. Other Events.
On February 20, 2003, West Pharmaceutical Services, Inc. (the "Company") issued
a press release concerning its fourth quarter and year-end results and provided
an update regarding the recent fire loss at its Kinston, North Carolina facility
and associated financial implications. The press release issued in connection
with this incident is filed as exhibit 99.1 to this report and is incorporated
herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits:
Exhibit # Description
99.1 Press Release dated February 20, 2003
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: February 24, 2003 By:
---------------------------------
Name: John R. Gailey III
Title: Vice President
EXHIBIT INDEX
99.1 Press Release dated February 20, 2003